2-Arylazetidines as ligands for nicotinic acetylcholine receptors

Alternative and complementary procedures were adopted for preparing 2-arylazetidine derivatives in moderate to good yields. Preliminary biological evaluation of 2-arylazetidines as ligands of nicotinic acetylcholine receptors allowed to identify chloro-substituted analogs as the most interesting congeners. The title compounds may be considered as suitable hit compounds for developing new nicotinic acetylcholine receptor ligands that may be safer than the currently available drugs targeting nicotinic acetylcholine receptors. Our described synthetic approaches enable facile access to a large number of diversely decorated azetidines for studying the structure–activity relationships and for refining the toxico-pharmacological profile of these agents.

This is a preview of subscription content, log in to check access.

Figure 1


  1. 1.

    Forgacs, P. B.; Bodis-Wollner, I. J. Neural Transm. 2004, 111, 1317.

    CAS  Article  Google Scholar 

  2. 2.

    (a) Hurst, R.; Rollema, H.; Bertrand, D. Pharmacol. Ther. 2013, 137, 22. (b) Dineley, K. T.; Pandya, A. A.; Yakel, J. L. Trends Pharmacol. Sci. 2015, 36, 96.

  3. 3.

    (a) Decker, M. W.; Meyer, M. D.; Sullivan, J. P. Expert Opin. Invest. Drugs 2001, 10, 1819. (b) Zhang, X.; Xiao, H. S. Curr. Opin. Mol. Ther. 2005, 7, 532. (c) Vincler, M. Expert Opin. Invest. Drugs 2005, 14, 1191. (d) Nirogi, R.; Goura, V; Abraham, R.; Jayarajan, P. Eur. J. Pharmacol. 2013, 712, 22.

  4. 4.

    Picciotto, M. R.; Lewis, A. S.; van Schalkwyk, G. I.; Mineur, Y. S. Neuropharmacology 2015, 96, 235.

    CAS  Article  Google Scholar 

  5. 5.

    Dwoskin, L. P.; Smith, A. M.; Wooters, T. E.; Zhang, Z.; Crooks, P. A.; Bardo, M. T. Biochem. Pharmacol. 2009, 78, 732.

    CAS  Article  Google Scholar 

  6. 6.

    Sacco, K. A.; Bannon, K. L.; George, T. P. J. Psychopharmacology 2004, 18, 457.

    CAS  Article  Google Scholar 

  7. 7.

    Quik, M.; Zhang, D.; Perez, X. A.; Bordia, T. Pharmacol. Ther. 2014, 144, 50.

    CAS  Article  Google Scholar 

  8. 8.

    (a) Kumari, V.; Postma, P. Neurosci. Biobehav. Rev. 2005, 29, 1021. (b) de Leon, J.; Diaz, F. J.; Aguilar, M. C.; Jurado, D.; Gurpegui, M. Schizophr. Res. 2006, 86, 256.

  9. 9.

    Lloyd, G. K.; Williams, M. J. Pharmacol. Exp. Ther. 2000, 292, 461.

    CAS  Google Scholar 

  10. 10.

    McEvoy, J. P.; Allen, T. B. Curr. Drug Targets: CNS Neurol. Disord. 2002, 1, 433.

    CAS  Google Scholar 

  11. 11.

    Czodrowski, P.; Mallinger, A.; Wienke, D.; Esdar, C.; Pöschke, O.; Busch, M.; Rohdich, F.; Eccles, S. A.; Ortiz-Ruiz, M.-J.; Schneider, R.; Raynaud, F. I.; Clarke, P. A.; Musil, D.; Schwarz, D.; Dale, T.; Urbahns, K.; Blagg, J.; Schiemann, K. J. Med. Chem. 2016, 59, 9337.

    CAS  Article  Google Scholar 

  12. 12.

    Jacobson, T. A.; Ito, M. K.; Maki, K. C.; Orringer, C. E.; Bays, H. E.; Jones, P. H.; McKenney, J. M.; Grundy, S. M.; Gill, E. A.; Wild, R. A.; Wilson, D. P.; Brown, W. V. J. Clin. Lipidol. 2015, 9, 129.

    Article  Google Scholar 

  13. 13.

    López-Muñoz, F.; Alamo, C. Curr. Pharm. Des. 2009, 15, 1563.

    Article  Google Scholar 

  14. 14.

    Changeux, J. P.; Edelstein, S. J. Neuron 1998, 21, 959.

    CAS  Article  Google Scholar 

  15. 15.

    (a) Brandi, A.; Cicchi, S.; Cordero, F. M. Chem. Rev. 2008, 108, 3988. (b) Han, J.-Q.; Zhang, H.-H.; Xu, P.-F.; Luo, Y.-C. Org. Lett. 2016, 18, 5212. (c) Takizawa, S.; Arteaga, F. A.; Yoshida, Y.; Suzuki, M.; Sasai, H. Org. Lett. 2013, 15, 4142. (d) Das, B.; Balasubramanyam, P.; Veeranjaneyulu, B.; Reddy, G. C. J. Org. Chem. 2009, 74, 9505.

  16. 16.

    (a) Degennaro, L.; Zenzola, M.; Trinchera, P.; Carroccia, L.; Giovine, A.; Romanazzi, G.; Falcicchio, A.; Luisi, R. Chem. Commun. 2014, 50, 1698. (b) Zenzola, M.; Degennaro, L.; Trinchera, P.; Carroccia, L.; Giovine, A.; Romanazzi, G.; Mastrorilli, P.; Rizzi, R.; Pisano, L.; Luisi, R. Chem.–Eur. J. 2014, 20, 12190. (c) De Angelis, S.; De Renzo, M.; Carlucci, C.; Degennaro, L.; Luisi R. Org. Biomol. Chem. 2016, 14, 4304.

  17. 17.

    (a) Parisi, G.; Zenzola, M.; Capitanelli, E.; Carlucci, C.; Romanazzi, G.; Pisano, L.; Degennaro, L.; Luisi, R. Pure Appl. Chem. 2016, 88, 631. (b) Parisi, G.; Capitanelli, E.; Pierro, A.; Romanazzi, G.; Clarkson, G. J.; Degennaro, L.; Luisi, R. Chem. Commun. 2015, 51, 15588. (c) De Ceglie, M. C.; Musio, B.; Affortunato, F.; Moliterni, A.; Altomare, A.; Florio, S.; Luisi, R. Chem.–Eur. J. 2011, 17, 286.

  18. 18.

    (a) Hopkins, A. L.; Keserü, G. M.; Leeson, P. D.; Rees, D. C.; Reynolds, C. H. Nat. Rev. Drug Discovery 2014, 13, 105. (b) Gualdani, R.; Cavalluzzi, M. M.; Lentini, G. Curr. Med. Chem. 2016, 23, 2289. (c) Gualdani, R.; Cavalluzzi, M. M.; Lentini, G.; Habtemariam, S. Molecules 2016, 21, 1530.

  19. 19.

    Hogg, R. C.; Bertrand, D. Biochem. Pharmacol. 2007, 73, 459.

    CAS  Article  Google Scholar 

  20. 20.

    Carocci, A.; Lentini, G.; Catalano, A.; Cavalluzzi, M. M.; Bruno, C.; Muraglia, M.; Colabufo, N. A.; Galeotti, N.; Corbo, F.; Matucci, R.; Ghelardini, C.; Franchini, C. ChemMedChem 2010, 5, 696.

    CAS  Article  Google Scholar 

  21. 21.

    Lo, M. M.-C., Fu, G. C. Tetrahedron 2001, 57, 2621.

    CAS  Article  Google Scholar 

  22. 22.

    Roselli, M.; Lentini, G.; Habtemariam, S. Phytother. Res. 2012, 26, 908.

    CAS  Article  Google Scholar 

  23. 23.

    Manni, M. E.; Bigagli, E.; Lodovici, M.; Zazzeri, M.; Raimondi, L. Pharmacol. Res. 2012, 65, 465.

    CAS  Article  Google Scholar 

Download references

We thank the University of Bari for support. We are grateful to Dr. Laura Carroccia for precious contribution to the work.

Author information



Corresponding authors

Correspondence to Renzo Luisi or Giovanni Lentini.

Additional information

Published in Khimiya Geterotsiklicheskikh Soedinenii, 2017, 53(3), 329–334

Electronic supplementary material

Below is the link to the electronic supplementary material.


(PDF 1445 kb)

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Degennaro, L., Zenzola, M., Laurino, A. et al. 2-Arylazetidines as ligands for nicotinic acetylcholine receptors. Chem Heterocycl Comp 53, 329–334 (2017). https://doi.org/10.1007/s10593-017-2061-5

Download citation


  • azetidine
  • ligand efficiency metrics
  • lipophilicity
  • neurodegeneration
  • nicotinic acetylcholine receptors
  • pain
  • schizophrenia
  • smoking cessation